Global Pharmacovigilance (PV) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

  • Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The focus of pharmacovigilance is on ADR (adverse drug reactions) and drug toxicity. The pharmacovigilance market comprises of all types of adverse events reporting conducted during clinical trials in hospitals, pharmacies, and other healthcare sectors.

    The Pharmacovigilance (PV) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.


    Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.


    In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Pharmacovigilance (PV) industry.

    Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

    In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.


    The Pharmacovigilance (PV) market can be split based on product types, major applications, and important countries as follows:


    Key players in the global Pharmacovigilance (PV) market covered in Chapter 12:

    IBM

    Wipro Limited

    Capgemini

    TAKE Solutions Ltd

    Cognizant

    Laboratory Corporation of America Holdings

    BioClinica

    ArisGlobal

    Foresight Group International AG

    Accenture

    PAREXEL International Corporation

    IT Clinical

    ICON PLC

    United BioSource Corporation


    In Chapter 4 and 14.1, on the basis of types, the Pharmacovigilance (PV) market from 2015 to 2025 is primarily split into:

    Spontaneous Reporting

    Intensified ADR Reporting

    Targeted Spontaneous Reporting

    Cohort Event Monitoring

    EHR Mining


    In Chapter 5 and 14.2, on the basis of applications, the Pharmacovigilance (PV) market from 2015 to 2025 covers:

    Hospitals

    Pharmaceutical Companies

    Other End Users


    Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

    North America (Covered in Chapter 7 and 14)

    United States

    Canada

    Mexico

    Europe (Covered in Chapter 8 and 14)

    Germany

    UK

    France

    Italy

    Spain

    Russia

    Others

    Asia-Pacific (Covered in Chapter 9 and 14)

    China

    Japan

    South Korea

    Australia

    India

    Southeast Asia

    Others

    Middle East and Africa (Covered in Chapter 10 and 14)

    Saudi Arabia

    UAE

    Egypt

    Nigeria

    South Africa

    Others

    South America (Covered in Chapter 11 and 14)

    Brazil

    Argentina

    Columbia

    Chile

    Others


    Years considered for this report:

    Historical Years: 2015-2019

    Base Year: 2019

    Estimated Year: 2020

    Forecast Period: 2020-2025

     

  • With tables and figures helping analyze worldwide Global Pharmacovigilance (PV) market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Table of Content

    1 Pharmacovigilance (PV) Introduction and Market Overview

    1.1 Objectives of the Study

    1.2 Overview of Pharmacovigilance (PV)

    1.3 Scope of The Study

    1.3.1 Key Market Segments
    1.3.2 Players Covered
    1.3.3 COVID-19's impact on the Pharmacovigilance (PV) industry

    1.4 Methodology of The Study

    1.5 Research Data Source


    2 Executive Summary

    2.1 Market Overview

    2.1.1 Global Pharmacovigilance (PV) Market Size, 2015 – 2020
    2.1.2 Global Pharmacovigilance (PV) Market Size by Type, 2015 – 2020
    2.1.3 Global Pharmacovigilance (PV) Market Size by Application, 2015 – 2020
    2.1.4 Global Pharmacovigilance (PV) Market Size by Region, 2015 - 2025

    2.2 Business Environment Analysis

    2.2.1 Global COVID-19 Status and Economic Overview
    2.2.2 Influence of COVID-19 Outbreak on Pharmacovigilance (PV) Industry Development

    3 Industry Chain Analysis

    3.1 Upstream Raw Material Suppliers of Pharmacovigilance (PV) Analysis

    3.2 Major Players of Pharmacovigilance (PV)

    3.3 Pharmacovigilance (PV) Manufacturing Cost Structure Analysis

    3.3.1 Production Process Analysis
    3.3.2 Manufacturing Cost Structure of Pharmacovigilance (PV)
    3.3.3 Labor Cost of Pharmacovigilance (PV)

    3.4 Market Distributors of Pharmacovigilance (PV)

    3.5 Major Downstream Buyers of Pharmacovigilance (PV) Analysis

    3.6 The Impact of Covid-19 From the Perspective of Industry Chain

    3.7 Regional Import and Export Controls Will Exist for a Long Time
    3.8 Continued downward PMI Spreads Globally

    4 Global Pharmacovigilance (PV) Market, by Type

    4.1 Global Pharmacovigilance (PV) Value and Market Share by Type (2015-2020)

    4.2 Global Pharmacovigilance (PV) Production and Market Share by Type (2015-2020)

    4.3 Global Pharmacovigilance (PV) Value and Growth Rate by Type (2015-2020)

    4.3.1 Global Pharmacovigilance (PV) Value and Growth Rate of Spontaneous Reporting
    4.3.2 Global Pharmacovigilance (PV) Value and Growth Rate of Intensified ADR Reporting
    4.3.3 Global Pharmacovigilance (PV) Value and Growth Rate of Targeted Spontaneous Reporting
    4.3.4 Global Pharmacovigilance (PV) Value and Growth Rate of Cohort Event Monitoring
    4.3.5 Global Pharmacovigilance (PV) Value and Growth Rate of EHR Mining

    4.4 Global Pharmacovigilance (PV) Price Analysis by Type (2015-2020)


    5 Pharmacovigilance (PV) Market, by Application

    5.1 Downstream Market Overview

    5.2 Global Pharmacovigilance (PV) Consumption and Market Share by Application (2015-2020)

    5.3 Global Pharmacovigilance (PV) Consumption and Growth Rate by Application (2015-2020)

    5.3.1 Global Pharmacovigilance (PV) Consumption and Growth Rate of Hospitals (2015-2020)
    5.3.2 Global Pharmacovigilance (PV) Consumption and Growth Rate of Pharmaceutical Companies (2015-2020)
    5.3.3 Global Pharmacovigilance (PV) Consumption and Growth Rate of Other End Users (2015-2020)

    6 Global Pharmacovigilance (PV) Market Analysis by Regions

    6.1 Global Pharmacovigilance (PV) Sales, Revenue and Market Share by Regions

    6.1.1 Global Pharmacovigilance (PV) Sales by Regions (2015-2020)
    6.1.2 Global Pharmacovigilance (PV) Revenue by Regions (2015-2020)

    6.2 North America Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    6.3 Europe Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    6.4 Asia-Pacific Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    6.5 Middle East and Africa Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    6.6 South America Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)


    7 North America Pharmacovigilance (PV) Market Analysis by Countries

    7.1 The Influence of COVID-19 on North America Market

    7.2 North America Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries

    7.2.1 North America Pharmacovigilance (PV) Sales by Countries (2015-2020)
    7.2.2 North America Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    7.3 United States Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    7.4 Canada Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    7.5 Mexico Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)


    8 Europe Pharmacovigilance (PV) Market Analysis by Countries

    8.1 The Influence of COVID-19 on Europe Market

    8.2 Europe Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries

    8.2.1 Europe Pharmacovigilance (PV) Sales by Countries (2015-2020)
    8.2.2 Europe Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    8.3 Germany Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    8.4 UK Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    8.5 France Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    8.6 Italy Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    8.7 Spain Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    8.8 Russia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    9 Asia Pacific Pharmacovigilance (PV) Market Analysis by Countries

    9.1 The Influence of COVID-19 on Asia Pacific Market

    9.2 Asia Pacific Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries

    9.2.1 Asia Pacific Pharmacovigilance (PV) Sales by Countries (2015-2020)
    9.2.2 Asia Pacific Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    9.3 China Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    9.4 Japan Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    9.5 South Korea Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    9.6 India Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    9.7 Southeast Asia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    9.8 Australia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    10 Middle East and Africa Pharmacovigilance (PV) Market Analysis by Countries

    10.1 The Influence of COVID-19 on Middle East and Africa Market

    10.2 Middle East and Africa Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries

    10.2.1 Middle East and Africa Pharmacovigilance (PV) Sales by Countries (2015-2020)
    10.2.2 Middle East and Africa Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    10.3 Saudi Arabia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    10.4 UAE Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    10.5 Egypt Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    10.6 Nigeria Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    10.7 South Africa Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    11 South America Pharmacovigilance (PV) Market Analysis by Countries

    11.1 The Influence of COVID-19 on Middle East and Africa Market

    11.2 South America Pharmacovigilance (PV) Sales, Revenue and Market Share by Countries

    11.2.1 South America Pharmacovigilance (PV) Sales by Countries (2015-2020)
    11.2.2 South America Pharmacovigilance (PV) Revenue by Countries (2015-2020)

    11.3 Brazil Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    11.4 Argentina Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    11.5 Columbia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)

    11.6 Chile Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)


    12 Competitive Landscape

    12.1 IBM

    12.1.1 IBM Basic Information
    12.1.2 Pharmacovigilance (PV) Product Introduction
    12.1.3 IBM Production, Value, Price, Gross Margin 2015-2020

    12.2 Wipro Limited

    12.2.1 Wipro Limited Basic Information
    12.2.2 Pharmacovigilance (PV) Product Introduction
    12.2.3 Wipro Limited Production, Value, Price, Gross Margin 2015-2020

    12.3 Capgemini

    12.3.1 Capgemini Basic Information
    12.3.2 Pharmacovigilance (PV) Product Introduction
    12.3.3 Capgemini Production, Value, Price, Gross Margin 2015-2020

    12.4 TAKE Solutions Ltd

    12.4.1 TAKE Solutions Ltd Basic Information
    12.4.2 Pharmacovigilance (PV) Product Introduction
    12.4.3 TAKE Solutions Ltd Production, Value, Price, Gross Margin 2015-2020

    12.5 Cognizant

    12.5.1 Cognizant Basic Information
    12.5.2 Pharmacovigilance (PV) Product Introduction
    12.5.3 Cognizant Production, Value, Price, Gross Margin 2015-2020

    12.6 Laboratory Corporation of America Holdings

    12.6.1 Laboratory Corporation of America Holdings Basic Information
    12.6.2 Pharmacovigilance (PV) Product Introduction
    12.6.3 Laboratory Corporation of America Holdings Production, Value, Price, Gross Margin 2015-2020
    12.7 BioClinica
    12.7.1 BioClinica Basic Information
    12.7.2 Pharmacovigilance (PV) Product Introduction
    12.7.3 BioClinica Production, Value, Price, Gross Margin 2015-2020
    12.8 ArisGlobal
    12.8.1 ArisGlobal Basic Information
    12.8.2 Pharmacovigilance (PV) Product Introduction
    12.8.3 ArisGlobal Production, Value, Price, Gross Margin 2015-2020
    12.9 Foresight Group International AG
    12.9.1 Foresight Group International AG Basic Information
    12.9.2 Pharmacovigilance (PV) Product Introduction
    12.9.3 Foresight Group International AG Production, Value, Price, Gross Margin 2015-2020

    12.10 Accenture

    12.10.1 Accenture Basic Information
    12.10.2 Pharmacovigilance (PV) Product Introduction
    12.10.3 Accenture Production, Value, Price, Gross Margin 2015-2020
    12.11 PAREXEL International Corporation
    12.11.1 PAREXEL International Corporation Basic Information
    12.11.2 Pharmacovigilance (PV) Product Introduction
    12.11.3 PAREXEL International Corporation Production, Value, Price, Gross Margin 2015-2020
    12.12 IT Clinical
    12.12.1 IT Clinical Basic Information
    12.12.2 Pharmacovigilance (PV) Product Introduction
    12.12.3 IT Clinical Production, Value, Price, Gross Margin 2015-2020
    12.13 ICON PLC
    12.13.1 ICON PLC Basic Information
    12.13.2 Pharmacovigilance (PV) Product Introduction
    12.13.3 ICON PLC Production, Value, Price, Gross Margin 2015-2020
    12.14 United BioSource Corporation
    12.14.1 United BioSource Corporation Basic Information
    12.14.2 Pharmacovigilance (PV) Product Introduction
    12.14.3 United BioSource Corporation Production, Value, Price, Gross Margin 2015-2020

    13 Industry Outlook

    13.1 Market Driver Analysis

    13.1.2 Market Restraints Analysis
    13.1.3 Market Trends Analysis

    13.2 Merger, Acquisition and New Investment

    13.3 News of Product Release


    14 Global Pharmacovigilance (PV) Market Forecast

    14.1 Global Pharmacovigilance (PV) Market Value & Volume Forecast, by Type (2020-2025)

    14.1.1 Spontaneous Reporting Market Value and Volume Forecast (2020-2025)
    14.1.2 Intensified ADR Reporting Market Value and Volume Forecast (2020-2025)
    14.1.3 Targeted Spontaneous Reporting Market Value and Volume Forecast (2020-2025)
    14.1.4 Cohort Event Monitoring Market Value and Volume Forecast (2020-2025)
    14.1.5 EHR Mining Market Value and Volume Forecast (2020-2025)

    14.2 Global Pharmacovigilance (PV) Market Value & Volume Forecast, by Application (2020-2025)

    14.2.1 Hospitals Market Value and Volume Forecast (2020-2025)
    14.2.2 Pharmaceutical Companies Market Value and Volume Forecast (2020-2025)
    14.2.3 Other End Users Market Value and Volume Forecast (2020-2025)

    14.3 Pharmacovigilance (PV) Market Analysis and Forecast by Region

    14.3.1 North America Market Value and Consumption Forecast (2020-2025)
    14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
    14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
    14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
    14.3.5 South America Market Value and Consumption Forecast (2020-2025)

    15 New Project Feasibility Analysis

    15.1 Industry Barriers and New Entrants SWOT Analysis

    15.1.1 Porter’s Five Forces Analysis
    15.1.2 New Entrants SWOT Analysis

    15.2 Analysis and Suggestions on New Project Investment



    List of Tables and Figures
    Figure Product Picture of Pharmacovigilance (PV)
    Table Product Specification of Pharmacovigilance (PV)
    Table Pharmacovigilance (PV) Key Market Segments
    Table Key Players Pharmacovigilance (PV) Covered
    Figure Global Pharmacovigilance (PV) Market Size, 2015 – 2025
    Table Different Types of Pharmacovigilance (PV)
    Figure Global Pharmacovigilance (PV) Value ($) Segment by Type from 2015-2020
    Figure Global Pharmacovigilance (PV) Market Share by Types in 2019
    Table Different Applications of Pharmacovigilance (PV)
    Figure Global Pharmacovigilance (PV) Value ($) Segment by Applications from 2015-2020
    Figure Global Pharmacovigilance (PV) Market Share by Applications in 2019
    Figure Global Pharmacovigilance (PV) Market Share by Regions in 2019
    Figure North America Pharmacovigilance (PV) Production Value ($) and Growth Rate (2015-2020)
    Figure Europe Pharmacovigilance (PV) Production Value ($) and Growth Rate (2015-2020)
    Figure Asia Pacific Pharmacovigilance (PV) Production Value ($) and Growth Rate (2015-2020)
    Figure Middle East and Africa Pharmacovigilance (PV) Production Value ($) and Growth Rate (2015-2020)
    Figure South America Pharmacovigilance (PV) Production Value ($) and Growth Rate (2015-2020)
    Table Global COVID-19 Status and Economic Overview
    Figure Global COVID-19 Status
    Figure COVID-19 Comparison of Major Countries
    Figure Industry Chain Analysis of Pharmacovigilance (PV)
    Table Upstream Raw Material Suppliers of Pharmacovigilance (PV) with Contact Information
    Table Major Players Headquarters, and Service Area of Pharmacovigilance (PV)
    Figure Major Players Production Value Market Share of Pharmacovigilance (PV) in 2019
    Table Major Players Pharmacovigilance (PV) Product Types in 2019
    Figure Production Process of Pharmacovigilance (PV)
    Figure Manufacturing Cost Structure of Pharmacovigilance (PV)
    Figure Channel Status of Pharmacovigilance (PV)
    Table Major Distributors of Pharmacovigilance (PV) with Contact Information
    Table Major Downstream Buyers of Pharmacovigilance (PV) with Contact Information
    Table Global Pharmacovigilance (PV) Value ($) by Type (2015-2020)
    Table Global Pharmacovigilance (PV) Value Share by Type (2015-2020)
    Figure Global Pharmacovigilance (PV) Value Share by Type (2015-2020)
    Table Global Pharmacovigilance (PV) Production by Type (2015-2020)
    Table Global Pharmacovigilance (PV) Production Share by Type (2015-2020)
    Figure Global Pharmacovigilance (PV) Production Share by Type (2015-2020)
    Figure Global Pharmacovigilance (PV) Value ($) and Growth Rate of Spontaneous Reporting (2015-2020)
    Figure Global Pharmacovigilance (PV) Value ($) and Growth Rate of Intensified ADR Reporting (2015-2020)
    Figure Global Pharmacovigilance (PV) Value ($) and Growth Rate of Targeted Spontaneous Reporting (2015-2020)
    Figure Global Pharmacovigilance (PV) Value ($) and Growth Rate of Cohort Event Monitoring (2015-2020)
    Figure Global Pharmacovigilance (PV) Value ($) and Growth Rate of EHR Mining (2015-2020)
    Figure Global Pharmacovigilance (PV) Price by Type (2015-2020)
    Figure Downstream Market Overview
    Table Global Pharmacovigilance (PV) Consumption by Application (2015-2020)
    Table Global Pharmacovigilance (PV) Consumption Market Share by Application (2015-2020)
    Figure Global Pharmacovigilance (PV) Consumption Market Share by Application (2015-2020)
    Figure Global Pharmacovigilance (PV) Consumption and Growth Rate of Hospitals (2015-2020)
    Figure Global Pharmacovigilance (PV) Consumption and Growth Rate of Pharmaceutical Companies (2015-2020)
    Figure Global Pharmacovigilance (PV) Consumption and Growth Rate of Other End Users (2015-2020)
    Figure Global Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Global Pharmacovigilance (PV) Revenue (M USD) and Growth (2015-2020)
    Table Global Pharmacovigilance (PV) Sales by Regions (2015-2020)
    Table Global Pharmacovigilance (PV) Sales Market Share by Regions (2015-2020)
    Table Global Pharmacovigilance (PV) Revenue (M USD) by Regions (2015-2020)
    Table Global Pharmacovigilance (PV) Revenue Market Share by Regions (2015-2020)
    Table Global Pharmacovigilance (PV) Revenue Market Share by Regions in 2015
    Table Global Pharmacovigilance (PV) Revenue Market Share by Regions in 2019
    Figure North America Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Europe Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Asia-Pacific Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Middle East and Africa Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure South America Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure North America COVID-19 Status
    Figure North America COVID-19 Confirmed Cases Major Distribution
    Figure North America Pharmacovigilance (PV) Revenue (M USD) and Growth (2015-2020)
    Table North America Pharmacovigilance (PV) Sales by Countries (2015-2020)
    Table North America Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
    Table North America Pharmacovigilance (PV) Revenue (M USD) by Countries (2015-2020)
    Table North America Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
    Figure United States Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Canada Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Mexico Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Europe COVID-19 Status
    Figure Europe COVID-19 Confirmed Cases Major Distribution
    Figure Europe Pharmacovigilance (PV) Revenue (M USD) and Growth (2015-2020)
    Table Europe Pharmacovigilance (PV) Sales by Countries (2015-2020)
    Table Europe Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
    Table Europe Pharmacovigilance (PV) Revenue (M USD) by Countries (2015-2020)
    Table Europe Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
    Figure Germany Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure UK Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure France Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Italy Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Spain Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Russia Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Asia Pacific COVID-19 Status
    Figure Asia Pacific Pharmacovigilance (PV) Revenue (M USD) and Growth (2015-2020)
    Table Asia Pacific Pharmacovigilance (PV) Sales by Countries (2015-2020)
    Table Asia Pacific Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
    Table Asia Pacific Pharmacovigilance (PV) Revenue (M USD) by Countries (2015-2020)
    Table Asia Pacific Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
    Figure China Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Japan Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure South Korea Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure India Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Southeast Asia Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Australia Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Middle East Pharmacovigilance (PV) Revenue (M USD) and Growth (2015-2020)
    Table Middle East Pharmacovigilance (PV) Sales by Countries (2015-2020)
    Table Middle East and Africa Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
    Table Middle East and Africa Pharmacovigilance (PV) Revenue (M USD) by Countries (2015-2020)
    Table Middle East and Africa Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
    Figure Saudi Arabia Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure UAE Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Egypt Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Nigeria Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure South Africa Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure South America Pharmacovigilance (PV) Revenue (M USD) and Growth (2015-2020)
    Table South America Pharmacovigilance (PV) Sales by Countries (2015-2020)
    Table South America Pharmacovigilance (PV) Sales Market Share by Countries (2015-2020)
    Table South America Pharmacovigilance (PV) Revenue (M USD) by Countries (2015-2020)
    Table South America Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
    Figure Brazil Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Argentina Pharmacovigilance (PV) Sales and Growth Rate (2015-2020)
    Figure Columbia Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Chile Pharmacovigilance (PV) Sales and Growth (2015-2020)
    Figure Top 3 Market Share of Pharmacovigilance (PV) Companies in 2019
    Figure Top 6 Market Share of Pharmacovigilance (PV) Companies in 2019
    Table Major Players Production Value ($) Share (2015-2020)
    Table IBM Profile
    Table IBM Product Introduction
    Figure IBM Production and Growth Rate
    Figure IBM Value ($) Market Share 2015-2020
    Table Wipro Limited Profile
    Table Wipro Limited Product Introduction
    Figure Wipro Limited Production and Growth Rate
    Figure Wipro Limited Value ($) Market Share 2015-2020
    Table Capgemini Profile
    Table Capgemini Product Introduction
    Figure Capgemini Production and Growth Rate
    Figure Capgemini Value ($) Market Share 2015-2020
    Table TAKE Solutions Ltd Profile
    Table TAKE Solutions Ltd Product Introduction
    Figure TAKE Solutions Ltd Production and Growth Rate
    Figure TAKE Solutions Ltd Value ($) Market Share 2015-2020
    Table Cognizant Profile
    Table Cognizant Product Introduction
    Figure Cognizant Production and Growth Rate
    Figure Cognizant Value ($) Market Share 2015-2020
    Table Laboratory Corporation of America Holdings Profile
    Table Laboratory Corporation of America Holdings Product Introduction
    Figure Laboratory Corporation of America Holdings Production and Growth Rate
    Figure Laboratory Corporation of America Holdings Value ($) Market Share 2015-2020
    Table BioClinica Profile
    Table BioClinica Product Introduction
    Figure BioClinica Production and Growth Rate
    Figure BioClinica Value ($) Market Share 2015-2020
    Table ArisGlobal Profile
    Table ArisGlobal Product Introduction
    Figure ArisGlobal Production and Growth Rate
    Figure ArisGlobal Value ($) Market Share 2015-2020
    Table Foresight Group International AG Profile
    Table Foresight Group International AG Product Introduction
    Figure Foresight Group International AG Production and Growth Rate
    Figure Foresight Group International AG Value ($) Market Share 2015-2020
    Table Accenture Profile
    Table Accenture Product Introduction
    Figure Accenture Production and Growth Rate
    Figure Accenture Value ($) Market Share 2015-2020
    Table PAREXEL International Corporation Profile
    Table PAREXEL International Corporation Product Introduction
    Figure PAREXEL International Corporation Production and Growth Rate
    Figure PAREXEL International Corporation Value ($) Market Share 2015-2020
    Table IT Clinical Profile
    Table IT Clinical Product Introduction
    Figure IT Clinical Production and Growth Rate
    Figure IT Clinical Value ($) Market Share 2015-2020
    Table ICON PLC Profile
    Table ICON PLC Product Introduction
    Figure ICON PLC Production and Growth Rate
    Figure ICON PLC Value ($) Market Share 2015-2020
    Table United BioSource Corporation Profile
    Table United BioSource Corporation Product Introduction
    Figure United BioSource Corporation Production and Growth Rate
    Figure United BioSource Corporation Value ($) Market Share 2015-2020
    Table Market Driving Factors of Pharmacovigilance (PV)
    Table Merger, Acquisition and New Investment
    Table Global Pharmacovigilance (PV) Market Value ($) Forecast, by Type
    Table Global Pharmacovigilance (PV) Market Volume Forecast, by Type
    Figure Global Pharmacovigilance (PV) Market Value ($) and Growth Rate Forecast of Spontaneous Reporting (2020-2025)
    Figure Global Pharmacovigilance (PV) Market Volume ($) and Growth Rate Forecast of Spontaneous Reporting (2020-2025)
    Figure Global Pharmacovigilance (PV) Market Value ($) and Growth Rate Forecast of Intensified ADR Reporting (2020-2025)
    Figure Global Pharmacovigilance (PV) Market Volume ($) and Growth Rate Forecast of Intensified ADR Reporting (2020-2025)
    Figure Global Pharmacovigilance (PV) Market Value ($) and Growth Rate Forecast of Targeted Spontaneous Reporting (2020-2025)
    Figure Global Pharmacovigilance (PV) Market Volume ($) and Growth Rate Forecast of Targeted Spontaneous Reporting (2020-2025)
    Figure Global Pharmacovigilance (PV) Market Value ($) and Growth Rate Forecast of Cohort Event Monitoring (2020-2025)
    Figure Global Pharmacovigilance (PV) Market Volume ($) and Growth Rate Forecast of Cohort Event Monitoring (2020-2025)
    Figure Global Pharmacovigilance (PV) Market Value ($) and Growth Rate Forecast of EHR Mining (2020-2025)
    Figure Global Pharmacovigilance (PV) Market Volume ($) and Growth Rate Forecast of EHR Mining (2020-2025)
    Table Global Market Value ($) Forecast by Application (2020-2025)
    Table Global Market Volume Forecast by Application (2020-2025)
    Figure Market Value ($) and Growth Rate Forecast of Hospitals (2020-2025)
    Figure Market Volume and Growth Rate Forecast of Hospitals (2020-2025)
    Figure Market Value ($) and Growth Rate Forecast of Pharmaceutical Companies (2020-2025)
    Figure Market Volume and Growth Rate Forecast of Pharmaceutical Companies (2020-2025)
    Figure Market Value ($) and Growth Rate Forecast of Other End Users (2020-2025)
    Figure Market Volume and Growth Rate Forecast of Other End Users (2020-2025)
    Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
    Figure North America Consumption and Growth Rate Forecast (2020-2025)
    Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
    Figure Europe Consumption and Growth Rate Forecast (2020-2025)
    Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
    Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
    Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
    Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
    Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
    Figure South America Consumption and Growth Rate Forecast (2020-2025)
    Figure Porter’s Five Forces Analysis
    Table New Entrants SWOT Analysis
    Table New Project Analysis of Investment Recovery

     

  • The Global Pharmacovigilance (PV) Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
      By Regions:
        By Type:
          By Application:
          Frequently asked questions(FAQ's):
          What gaps and opportunities are seen in the Global Pharmacovigilance (PV) Market?

          The flow of investment into the Global Pharmacovigilance (PV) Market, which is utilizing technologies to drive efficiency and high volume, clearly shows the market opportunity.

          What are the major applications for Global Pharmacovigilance (PV)?

          Global Pharmacovigilance (PV) has a wide range of applications, including and others.

          What is the anticipated growth rate for the Global Pharmacovigilance (PV) Market?

          During the projected year from 2024 to 2029, the Global Pharmacovigilance (PV) Market is expected to grow at a CAGR of xx%.

          Is further segmentation possible given the scope of the Global Pharmacovigilance (PV) Market study?

          Yes, the add-on segmentation is available in the premium customised version of the Global Pharmacovigilance (PV) Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.

          Who should consider the Global Pharmacovigilance (PV) Market study?

          The Global Pharmacovigilance (PV) Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.

          Our Clients